최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of Korean academy of nursing = 대한간호학회지, v.42 no.5, 2012년, pp.644 - 658
박진희 (아주대학교 간호대학) , 배선형 (연세대학교 간호대학)
Purpose: The purpose of this study was to evaluate the cognitive effects of chemotherapy in patients with breast cancer. Methods: Using several databases, prospective studies were collected up to August 2011. Of 2,106 publications identified, 12 met the inclusion criteria, and 8 studies were used to...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
화학요법은 유방암 환자에게 어떠한 위험성이 있는가? | 화학요법은 대부분 유방암 환자에게 적용되는 보조적 요법으로 유방암 환자의 재발률을 감소시키고 생존율을 증가시켜왔다. 그러나 화학요법을 받은 유방암 환자들은 갑작스러운 폐경이나, 성기능 저하, 인지장애, 골다공증과 같은 이차적인 건강문제에 노출된다(Knobf, 2011; Matsuda et al., 2005). | |
유방암 환자에서 화학요법관련 인지장애 발생률은? | ). 유방암 환자에서 CRCI의 발생률은 17-75%으로 보고되고 있으며(Myers, 2009), 이 중 17-35% 정도는 장기간 지속되는 중증 이상의 CRCI를 경험하는 것으로 알려져있다(Ahles&Saykin, 2002; Myers). | |
인지기능이란? | 인지기능은 인간이 사고나 감지의 대상을 생각하고 느끼고 기억하는 과정을 의미하는 대뇌 피질의 기능으로 정보를 선택, 습득, 분류, 통합하는 수용기능, 정보의 저장과 인출을 나타내는 기억과 학습,정보의정신적조직과재조직하는사고,정보를의사소통하거나 행위를 하는 표현기능을 의미한다(Lezak, Howieson, & Loring, 2004). 화학요법은 유방암 환자에게 주의집중력, 집행기능, 정보처리속도, 언어 및 시각기억력 및 정신운동 영역 등 전반적인 영역에서 인지기능 저하를 유발하는 것으로 알려져 있으며(Falleti, Sanfilippo, Maruff, Weih, & Phillips, 2005; Stewart, Bielajew, Collins, Parkinson,&Tomiak, 2006), 화학요법 종료부터 주로 언어기억력, 시각기억력 및 정신운동처리속도가 저하되기 시작하며 일부에서는 인지기능의 저하와 장애가 10년 이상 지속되기도 한다(Ahles & Saykin, 2002). |
Ahles, T. A., & Saykin, A. J. (2002). Breast cancer chemotherapy-related cognitive dysfunction. Clinical Breast Cancer, 3(Suppl 3), S84-S90. http://dx.doi.org/10.3816/CBC.2002.s.018
Ahles, T. A., Saykin, A. J., McDonald, B. C., Li, Y., Furstenberg, C. T., Hanscom, B. S., et al. (2010). Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: Impact of age and cognitive reserve. Journal of Clinical Oncology, 28, 4434-4440. http://dx.doi.org/10.1200/JCO.2009.27.0827
Bender, C. M., Sereika, S. M., Berga, S. L., Vogel, V. G., Brufsky, A. M., Paraska, K. K., et al. (2006). Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-Oncology, 15, 422-430. http://dx.doi.org/10.1002/pon.964
Braver, T. S., & Barch, D. M. (2002). A theory of cognitive control, aging cognition, and neuromodulation. Neuroscience and Biobehavioral Reviews, 26, 809-817. http://dx.doi.org/10.1016/S0149-7634(02)00067-2
Collins, B., Mackenzie, J., Stewart, A., Bielajew, C., & Verma, S. (2009). Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment. Psycho-Oncology, 18, 134-143. http://dx.doi.org/10.1002/pon.1379
Cusimano, A. (2001). Learning disabilities: There is a cure. Pennsylvania, PA: Achieve Publications.
Debess, J., Riis, J. O., Engebjerg, M. C., & Ewertz, M. (2010). Cognitive function after adjuvant treatment for early breast cancer: A population-based longitudinal study. Breast Cancer Research and Treatment, 121, 91-100. http://dx.doi.org/10.1007/s10549-010-0756-8
DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7, 177-188. http://dx.doi.org/10.1016/0197-2456(86)90046-2
Egger, M., Davey Smith, G. D., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. British Medical Journal, 315, 629-634. http://dx.doi.org/10.1136/bmj.315.7109.629
Falleti, M. G., Sanfilippo, A., Maruff, P., Weih, L., & Phillips, K. A. (2005). The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta-analysis of the current literature. Brain and Cognition, 59, 60-70. http://dx.doi.org/10.1016/j.bandc.2005.05.001
Fan, H. G., Houede-Tchen, N., Yi, Q. L., Chemerynsky, I., Downie, F. P., Sabate, K., et al. (2005). Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1-and 2-year follow-up of a prospective controlled study. Journal of Clinical Oncology, 23, 8025-8032. http://dx.doi.org/10.1200/JCO.2005.01.6550
Gazzaniga, M. S., Ivry, R. B., & Mangun, G. R. (2002). Cognitive neuroscience: The biology of the mind (2nd ed.). New York, NY: W.W. Norton & Company.
Glogoski, C., Milligan, N. V., & Wheatley, C. J. (2006). Evaluation and treatment of cognitive dysfunction. In H. M. Pendleton & W. Schultz-Krohn (Eds.), Pedretti's occupational therapy: Practice skills for physical dysfunction (6th ed.)(pp. 589-608). St. Louis, MO: Mosby Elsevier.
Isaki, E., Spaulding, T. J., & Plante, E. (2008). Contributions of language and memory demands to verbal memory performance in language-learning disabilities. Journal of Communication Disorders, 41, 512-530. http://dx.doi.org/10.1016/j.jcomdis.2008.03.006
Jansen, C. E., Miaskowski, C. A., Dodd, M. J., & Dowling, G. A. (2007). A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer. Oncology Nursing Forum, 34, 997-1005. http://dx.doi.org/10.1188/07.ONF.997-1005
Knobf, M. T. (2011). Clinical update: Psychosocial responses in breast cancer survivors. Seminars in Oncology Nursing, 27, e1-e14. http://dx.doi.org/10.1016/j.soncn.2011.05.001
Korean National Statistical Office. (2009). Annual report on cause of death statistics. Seoul: Author.
Lezak, M. D., Howieson, D. B., & Loring, D. W. (2004). Neuropsychological assessment (4th ed.). New York, NY: Oxford University Press.
Matsuda, T., Takayama, T., Tashiro, M., Nakamura, Y., Ohashi, Y., & Shimozuma, K. (2005). Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients-evaluation of appropriate research design and methodology to measure symptoms. Breast Cancer, 12, 279-287. http://dx.doi.org/10.2325/jbcs.12.279
Myers, J. S. (2009). Chemotherapy-related cognitive impairment. Clinical Journal of Oncology Nursing, 13, 413-421. http://dx.doi.org/10.1188/09.CJON.413-421
National Evidence-based Healthcare Collaborating Agency. (2011). NECA's guidance for systematic review for new health technology assessment. Seoul: Author.
Nelson, C. J., Nandy, N., & Roth, A. J. (2007). Chemotherapy and cognitive deficits: Mechanisms, findings, and potential interventions. Palliative and Supportive Care, 5, 273-280. http://dx.doi.org/10.1017/S1478951507000442
Noal, S., Levy, C., Hardouin, A., Rieux, C., Heutte, N., Segura, C., et al. (2011). One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer. International Journal of Radiation Oncology, Biology, Physics, 81, 795-803. http://dx.doi.org/10.1016/j.ijrobp.2010.06.037
Ouimet, L. A., Stewart, A., Collins, B., Schindler, D., & Bielajew, C. (2009). Measuring neuropsychological change following breast cancer treatment: An analysis of statistical models. Journal of Clinical and Experimental Neuropsychology, 31, 73-89. http://dx.doi.org/10.1080/13803390801992725
Quesnel, C., Savard, J., & Ivers, H. (2009). Cognitive impairments associated with breast cancer treatments: Results from a longitudinal study. Breast Cancer Research and Treatment, 116, 113-123. http://dx.doi.org/10.1007/s10549-008-0114-2
Rosenthal, R. (1991). Meta-analytic procedures for social research. Newbury Park, CA: Sage Publications.
Scottish Intercollegiate Guidelines Network. (2011). SIGN 50: A guideline developer's handbook. Retrieved January, 11, 2012, from http://www.sign.ac.uk/pdf/sign50.pdf
Stewart, A., Bielajew, C., Collins, B., Parkinson, M., & Tomiak, E. (2006). A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. The Clinical Neuropsychologist, 20, 76-89. http://dx.doi.org/10.1080/138540491005875
Tager, F. A., McKinley, P. S., Schnabel, F. R., El-Tamer, M., Cheung, Y. K., Fang, Y., et al. (2010). The cognitive effects of chemotherapy in post-menopausal breast cancer patients: A controlled longitudinal study. Breast cancer Research and Treatment, 123, 25-34. http://dx.doi.org/10.1007/s10549-009-0606-8
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.